Skip to main content

Advertisement

Log in

Time trends in stroke severity in the years 2005 to 2020: results from the Austrian Stroke Unit Registry

  • Original Communication
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Background and purpose

With aging population, there is an increase of atrial fibrillation (AF) and other vascular risk factors. We investigated trends in stroke severity at hospital admission with respect to AF and other risk factors in a prospective national stroke registry from 2005 to 2020.

Methods

Data from the prospective Austrian Stroke Unit Registry were used to study demographic and clinical factors associated with the change in admission stroke severity over years. Time trends in admission stroke severity of patients with pre-stroke modified Rankin Score ≤ 3 were investigated with respect to clinical variables and predefined age groups 18–54, 55–64, 65–74, 75–84 and ≥ 85 years. Time trends were studied using robust generalized linear models assuming normal distribution with a log link. Stroke severity on admission was assessed according to the National Institutes of Health Stroke Scale Score (NIHSS).

Results

In total, 140,312 patients with acute ischemic stroke were included in the analysis. Within the study period, mean patients’ age increased from 70 to 72 years (p < 0.001) and median NIHSS at admission decreased from 4 to 3 (p < 0.001). The frequency of AF increased from 25 to 32% (p < 0.001). The decrease in median admission NIHSS was evident in all relevant subgroups but more pronounced in patients with risk factors including AF, diabetes, hypercholesterolemia, smoking, elderly patients and those with pre-stroke disability.

Conclusion

Despite an aging population and generally increasing AF frequency, we observed a consistent trend towards less disabling strokes on admission.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Rothwell PM, Coull AJ, Giles MF, Howard SC, Silver LE, Bull LM et al (2004) Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet 363(9425):1925–1933

    Article  CAS  Google Scholar 

  2. Lackland DT, Roccella EJ, Deutsch AF, Fornage M, George MG, Howard G et al (2014) Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association. Stroke 45(1):315–353

    Article  Google Scholar 

  3. Nezu T, Hosomi N, Lip GY, Aoki S, Shimomura R, Maruyama H et al (2016) Temporal trends in stroke severity and prior antithrombotic use among acute ischemic stroke patients in Japan. Circ J 80(9):2033–2036

    Article  Google Scholar 

  4. Koton S, Geva D, Streifler JY, Harnof S, Pougach Y, Azrilin O et al (2018) Declining rate and severity of hospitalized stroke from 2004 to 2013: the National Acute Stroke Israeli Registry. Stroke 49(6):1348–1354

    Article  Google Scholar 

  5. Teuschl Y, Brainin M, Matz K, Dachenhausen A, Ferrari J, Seyfang L et al (2013) Time trends in patient characteristics treated on acute stroke-units: results from the Austrian Stroke Unit Registry 2003–2011. Stroke 44(4):1070–1074

    Article  Google Scholar 

  6. Hajat C, Heuschmann PU, Coshall C, Padayachee S, Chambers J, Rudd AG et al (2011) Incidence of aetiological subtypes of stroke in a multi-ethnic population based study: the South London Stroke Register. J Neurol Neurosurg Psychiatry 82(5):527–533

    Article  Google Scholar 

  7. Dulli DA, Stanko H, Levine RL (2003) Atrial fibrillation is associated with severe acute ischemic stroke. Neuroepidemiology 22(2):118–123

    Article  Google Scholar 

  8. Yiin GS, Howard DP, Paul NL, Li L, Mehta Z, Rothwell PM et al (2017) Recent time trends in incidence, outcome and premorbid treatment of atrial fibrillation-related stroke and other embolic vascular events: a population-based study. J Neurol Neurosurg Psychiatry 88(1):12–18

    Article  Google Scholar 

  9. Ogilvie IM, Newton N, Welner SA, Cowell W, Lip GY (2010) Underuse of oral anticoagulants in atrial fibrillation: a systematic review. Am J Med 123(7):638-45e4

    Article  CAS  Google Scholar 

  10. Gladstone DJ, Bui E, Fang J, Laupacis A, Lindsay MP, Tu JV et al (2009) Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated. Stroke 40(1):235–240

    Article  CAS  Google Scholar 

  11. Seelig J, Verheugt FWA, Hemels MEW, Illingworth L, Lucassen A, Adriaansen H et al (2020) Changes in anticoagulant prescription in Dutch patients with recent-onset atrial fibrillation: observations from the GARFIELD-AF registry. Thromb J 18:5

    Article  CAS  Google Scholar 

  12. Steinberg BA, Gao H, Shrader P, Pieper K, Thomas L, Camm AJ et al (2017) International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation: Results from the GARFIELD-AF, ORBIT-AF I, and ORBIT-AF II registries. Am Heart J 194:132–140

    Article  CAS  Google Scholar 

  13. Reichardt B. Therapie des Vorhofflimmerns. Konsensus Heilmittelökonomie. 2017.***

  14. Steiner MM, Brainin M, Austrian Stroke Registry for Acute Stroke U (2003) The quality of acute stroke units on a nation-wide level: the Austrian Stroke Registry for acute stroke units. Eur J Neurol 10(4):353–360

    Article  CAS  Google Scholar 

  15. Brott T, Adams HP Jr, Olinger CP, Marler JR, Barsan WG, Biller J et al (1989) Measurements of acute cerebral infarction: a clinical examination scale. Stroke 20(7):864–870

    Article  CAS  Google Scholar 

  16. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL et al (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24(1):35–41

    Article  Google Scholar 

  17. Sakamoto Y, Okubo S, Sekine T, Nito C, Suda S, Matsumoto N et al (2018) Prior direct oral anticoagulant therapy is related to small infarct volume and no major artery occlusion in patients with stroke and non-valvular atrial fibrillation. J Am Heart Assoc 7(17):e009507

    Article  Google Scholar 

  18. Jung YH, Kim YD, Kim J, Han SW, Oh MS, Lee JS et al (2020) Initial stroke severity in patients with atrial fibrillation according to antithrombotic therapy before Ischemic stroke. Stroke 51(9):2733–2741

    Article  Google Scholar 

  19. Tomita H, Hagii J, Metoki N, Saito S, Shiroto H, Hitomi H et al (2015) Severity and functional outcome of patients with cardioembolic stroke occurring during non-vitamin K antagonist oral anticoagulant treatment. J Stroke Cerebrovasc Dis 24(6):1430–1437

    Article  Google Scholar 

  20. Xian Y, O’Brien EC, Liang L, Xu H, Schwamm LH, Fonarow GC et al (2017) Association of preceding antithrombotic treatment with acute ischemic stroke severity and in-hospital outcomes among patients with atrial fibrillation. JAMA 317(10):1057–1067

    Article  Google Scholar 

  21. Hoyer C, Filipov A, Neumaier-Probst E, Szabo K, Ebert A, Alonso A (2018) Impact of pre-admission treatment with non-vitamin K oral anticoagulants on stroke severity in patients with acute ischemic stroke. J Thromb Thrombolysis 45(4):529–535

    Article  CAS  Google Scholar 

  22. Gadsboll K, Staerk L, Fosbol EL, Sindet-Pedersen C, Gundlund A, Lip GYH et al (2017) Increased use of oral anticoagulants in patients with atrial fibrillation: temporal trends from 2005 to 2015 in Denmark. Eur Heart J 38(12):899–906

    PubMed  Google Scholar 

  23. Camm AJ, Accetta G, Ambrosio G, Atar D, Bassand JP, Berge E et al (2017) Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation. Heart 103(4):307–314

    Article  Google Scholar 

  24. Suzuki S, Otsuka T, Sagara K, Semba H, Kano H, Matsuno S et al (2016) Nine-year trend of anticoagulation use, thromboembolic events, and major bleeding in patients with non-valvular atrial fibrillation- shinken database analysis. Circ J 80(3):639–649

    Article  CAS  Google Scholar 

  25. Cowan JC, Wu J, Hall M, Orlowski A, West RM, Gale CP (2018) A 10 year study of hospitalized atrial fibrillation-related stroke in England and its association with uptake of oral anticoagulation. Eur Heart J 39(32):2975–2983

    Article  Google Scholar 

  26. Yiin GSC, Li L, Bejot Y, Rothwell PM (2018) Time trends in atrial fibrillation-associated stroke and premorbid anticoagulation. Stroke. https://doi.org/10.1161/STROKEAHA.118.022249

    Article  PubMed  PubMed Central  Google Scholar 

  27. Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD et al (2014) Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet 383(9921):955–962

    Article  CAS  Google Scholar 

  28. Wolf PA, Abbott RD, Kannel WB (1991) Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 22(8):983–988

    Article  CAS  Google Scholar 

  29. Bogiatzi C, Hackam DG, McLeod AI, Spence JD (2014) Secular trends in ischemic stroke subtypes and stroke risk factors. Stroke 45(11):3208–3213

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank all Austrian Stroke Unit Registry collaborators. Austrian Stroke Unit Registry Collaborators (Co-Investigators) Johannes Sebastian Mutzenbach, MD (Christian-Doppler-Clinic, Salzburg); Nele Bubel, MD (Christian-Doppler-Clinic, Salzburg); Katharina Millesi, MD (Christian-Doppler-Clinic, Salzburg); Regina Katzenschlager, MD (Donauspital, Vienna); Sabine Torma, MD (Donauspital, Vienna); Miroslav Krstic, MD (Donauspital, Vienna); Franz Gruber, MD (General Hospital, Linz); Milan R.Vosko, MD (General Hospital, Linz); Cornelia Brunner, MD (General Hospital, Linz), Michael Brainin, MD (Hospital Donauregion, Tulln); Karl Matz, MD (Hospital Donauregion, Tulln); Yvonne Teuschl, MD (Hospital Donauregion); Omid Hosseiny, MD (Hospital Göttlicher Heiland ,Vienna); Wolf Muellbacher, MD (Hospital Göttlicher Heiland,Vienna); Dietlind Resch, MD (Hospital Hietzing, Vienna); Martina Mayr, MD (Hospital Hietzing, Vienna) Robert Paur, MD (Hospital Hietzing, Vienna); Otto Berger, MD (Hospital Kaiser Franz-Josef, Vienna);Vera Nussgruber,MD (Hospital Kaiser Franz-Josef, Vienna);Wolfgang Grisold, MD (Hospital Kaiser Franz-Josef, Vienna); Joerg Weber, MD (Hospital Klagenfurt); Heinz Kohlfuerst, MD ( Hospital Klagenfurt); Klaus Berek, MD (Hospital Kufstein); Maertin Sawires, MD (Hospital Kufstein);Stefan Haaser, MD (Hospital Kufstein); Susanne Asenbaum-Nan, MD (Hospital Mostviertel, Amstetten); Awini Barwari, MD (Hospital Mostviertel, Amstetten); Sarah Doerfler, MD (Hospital Mostviertel, Amstetten); Stefan Oberndorfer (Hospital St. Poelten); Andreas Gatterer (Hospital St. Poelten); Alexander Tinchon (Hospital St. Poelten);Alexandra Herbst, MD (Hospital Oberwart);Barbara Muellauer, MD (Hospital Oberwart); Eva Schubert-Vadon, MD (Hospital Oberwart); Christian Eggers, MD (Hospital of the Mercy Friars Linz);Christof Bocksrucker, MD (Hospital of the Mercy Friars Linz);Andrea Hackenbuchner, MD (Hospital Otto Wagner, Vienna); Martin Krichmayr, MD (Hospital Rudolfstiftung, Vienna);Peter Sommer, MD (Hospital Rudolfstiftung, Vienna); Elisabeth Fertl, MD (Hospital Rudolfstiftung, Vienna); Herbert Koller, MD (Hospital LSF Graz); Franz-Stefan Höger, MD (Hospital LSF, Graz); Nenad Mitrovic, MD (Hospital Vöcklabruck); Thomas Salletmayr, MD (Hospital Vöcklabruck); Monika Grunenberg, MD (Hospital Vöcklabruck);Hanspeter Haring, MD (Hospital Wagner-Jauregg, Linz); Nakajima Takeshi, MD (Hospital Waldviertel Horn);Alexandra Rieseneder, MD (Hospital Waldviertel Horn); Martin Gabler (Hospital Waldviertel Horn); Andreas Doppelbauer, MD (Hospital Weinviertel Mistelbach); Stefan Pingitzer, MD (Hospital Weinviertel Mistelbach); Manfred Eder; MD (Hospital Weinviertel Mistelbach);Peter Schnider, MD (Hospital Wiener Neustadt); Isabelle Csmarich, MD(Hospital Wiener Neustadt); Andrea Hager-Seifert,MD (Hospital Wiener Neustadt); Franz Fazekas, MD (Medical University of Graz); Kurt Niederkorn, MD (Medical University of Graz), Thomas Gattringer, MD (Medical University of Graz); Johann Willeit, MD (Medical University of Innsbruck); Michael Knoflach, MD (Medical University of Innsbruck); Stefan Kiechl, MD (Medical University of Innsbruck); Claude Alf, MD (Neurological Center Rosenhügel, Hospital Hietzing Vienna -1st Dept. of Neurology);Georg Dimitriadis, MD (Neurological Center Rosenhügel, Hospital Hietzing Vienna -1st Dept. of Neurology); Manfred Schmidbauer, MD (Neurological Center Rosenhügel, Hospital Hietzing Vienna -1st Dept. of Neurology); Elsa Fröschl, MD (Neurological Center Rosenhügel, Hospital Hietzing Vienna -2nd Dept. of Neurology);Christoph Baumgartner, MD (Neurological Center Rosenhügel, Hospital Hietzing Vienna -2nd Dept. of Neurology); Judith Stanek, MD (Wilhelminen Hospital, Vienna); Gerhard Daniel, MD (Wilhelminen Hospital, Vienna);Silvia Parigger , MD (Wilhelminen Hospital, Vienna);Josef Grossmann, MD (Hospital Lienz);Martin Kosco, MD (Hospital Lienz); Robert Perfler, MD (Hospital Lienz);Sylvia Promisch, MD (Hospital LKH Villach); Peter Kapeller, MD (Hospital LKH Villach);Magret Niederkorn-Duft, MD (Hospital LKH Knittelfeld); Philipp Werner, MD (LKH Feldkirch); Wolfgang Serles (Medical University of Vienna); Eduard Auff (Medical UniversityofVienna); Martin Heine, MD (Hospital Feldbach); Harald Wurzinger, MD(Hospital Feldbach); Gesundheit Österreich GmbH/BIQG (M. Moritz, A. Gollmer,R. Kern,), Steering Group at the GÖG/BIQG

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Marek Sykora.

Ethics declarations

Conflicts of interest

None.

Additional information

The members of the the Austrian Stroke Unit Registry Collaborators are mentioned "Acknowledgments section".

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bernegger, A., Mikšová, D., Posekany, A. et al. Time trends in stroke severity in the years 2005 to 2020: results from the Austrian Stroke Unit Registry. J Neurol 269, 4396–4403 (2022). https://doi.org/10.1007/s00415-022-11079-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-022-11079-x

Keywords

Navigation